As per DelveInsight, the growth of the Occlusion Devices Market from 2023 to 2028 is driven primarily by the expanding population of patients with chronic illnesses. The aging population and the rise in chronic diseases have created a greater demand for minimally invasive treatment options that can improve patient quality of life. Additionally, the growing awareness and adoption of minimally invasive procedures by both patients and healthcare providers have fueled the demand for occlusion devices. Advancements in medical technology and techniques have expanded the scope of interventional procedures, leading to an increased need for specialized devices. Moreover, occlusion devices offer cost-effectiveness by reducing hospital stays, minimizing the need for lengthy recovery periods, and lowering the risk of complications associated with traditional surgeries. As a result, healthcare systems and providers are increasingly recognizing the benefits of occlusion devices, leading to a surge in demand.
Some of the leading MedTech giants in the Global Occlusion Devices Market include Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others.
DelveInsight’s “Occlusion Devices Market Insight, Competitive Landscape, and Market Forecast 2028” research report provides the current and forecasted Occlusion Devices market size, share, and trends analysis for the next five years. Moreover, it highlights the ongoing innovations in the segment, major market drivers & barriers, key competitors, and emerging devices in the domain
Occlusion Devices Market: Overview
Occlusion devices are medical devices designed to selectively or completely block blood flow in a specific blood vessel or cavity within the body. They are utilized in various medical procedures to treat conditions such as aneurysms, embolisms, and vascular malformations. These devices play a crucial role in interventional radiology and minimally invasive surgeries, providing physicians with a safe and effective means of controlling blood flow and preventing further complications.
The importance of occlusion devices lies in their ability to address critical medical conditions while minimizing the invasiveness of traditional surgical procedures. By offering a less invasive alternative, occlusion devices reduce the risks associated with open surgeries, decrease patient recovery time, and improve overall patient outcomes. These devices provide a targeted approach, allowing physicians to precisely control blood flow and deliver treatment directly to the affected area, thus reducing potential damage to surrounding healthy tissues.
Overall, occlusion devices play a vital role in modern medicine, enabling targeted treatment and improved patient outcomes. With the increasing demand driven by technological advancements, patient preferences, and cost-effectiveness, the development and availability of innovative occlusion devices are poised to continue growing in the healthcare industry.
To provide a better understanding of the market dynamics, DelveInsight’s “Occlusion Devices Market” report provides an in-depth assessment of the market by product type (embolization devices, occlusion removal devices [coil retrievers, stent retrievers, and others], and support devices), application (oncology, cardiology, vascular diseases, neurology, and others), end-user (hospitals, surgical centers, and others), and geography (North America, Europe, Asia-pacific, and rest of the world). In the application segment of the occlusion devices market, the neurology category is expected to amass a significant revenue share in the year 2022.
Occlusion Devices Market Analysis
The occlusion devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of cardiovascular diseases. Cardiovascular diseases, such as coronary artery disease, peripheral arterial disease, and cerebrovascular disease, often involve blockages or occlusions in blood vessels. As per the estimate, about 550 million people were living with heart and circulatory diseases in 2022, across the world. Furthermore, ischemic heart disease is one of the most common cardiovascular disorders, affecting 200 million people, followed by peripheral arterial (vascular) disease with 110 million people, stroke with 100 million people, and atrial fibrillation affecting 60 million people in 2022, globally.
Occlusion devices are utilized to effectively block or close off these vessels, restoring proper blood flow and treating the underlying condition. Cardiovascular diseases are more prevalent among the elderly population. As the global population continues to age, the incidence of cardiovascular diseases increases. This demographic shift contributes to the growing demand for occlusion devices to manage and treat these conditions in the aging population. Occlusion devices play a crucial role in minimally invasive procedures for cardiovascular diseases. Furthermore, occlusion devices help in avoiding disadvantages associated with surgical procedures, such as surgical scarring and inflammation after stent implantation. Overall, the increasing prevalence of cardiovascular diseases drives the demand for occlusion devices as they are essential tools for the treatment of blockages and occlusions, enable minimally invasive approaches, align with the preference for less invasive procedures, cater to the needs of the aging population, and benefit from ongoing technological advancements in the field.
Technological advancements are another key factor driving the demand for Occlusion Devices. Technological advancements in occlusion devices have improved their efficacy, safety, and ease of use. These advancements have resulted in better outcomes for patients undergoing cardiovascular procedures, further driving the demand for occlusion devices. However, surgery-related complications, stringent regulatory framework, and others can impose a challenge to occlusion device market growth.
Interested to know more about the ongoing developments in the market? Visit to get an in-depth insight @ Occlusion Devices Types and Emerging Products
Occlusion Devices – Global Market Assessment and Forecast
Among all the regions, North America is estimated to account for the largest share of the occlusion devices market in the coming years. This can be attributed to several significant factors contributing to growth in the region. The increasing prevalence of cardiovascular diseases is one of the key factors. As per the estimate, every year, about 805,000 people in the United States suffer from heart attacks, especially among most racial and ethnic groups in the United States. Moreover, in 2021, about 18.2 million adults of age 20 years and older had coronary artery disease, and about 360,900 people died in 2019 due to coronary heart disease. As a result, more operations are anticipated due to the high mortality rate from cardiovascular diseases in the nation.
Moreover, the rising prevalence of cancer in the US is also considered a key factor in the growing demand for occlusion devices. In 2023, nearly 1,958,310 new cancer cases are projected to occur in the United States. The increasing incidence of cancer is expected to drive the demand for interventional procedures in the region, thereby increasing the demand for occlusion devices, as these devices work by stopping the blood flow toward tumors. The rising cases of cancer and neurological conditions such as brain aneurysms, advancements in occlusion devices, and government initiatives aimed at creating awareness and promoting disease treatment are also expected to have a favorable impact on the Occlusion Devices.
Interested in knowing how the Occlusion Devices market will grow by 2028? Click to get a snapshot @ Occlusion Devices Market Trends and Developments
Occlusion Devices Market – Key Developments and Breakthroughs
Over the years, the Occlusion Devices market has evolved significantly, owing to the active participation of global MedTech companies and technological advancements in the domain. Similarly, several clinical, commercial, and regulatory developments have also been registered in the domain.
Some of the major advancements in the Occlusion Devices market in recent years include –
- In February 2022, Front Line Medical Technologies announced the availability and distribution of COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) which is strong enough to hold back aortic pressure and allows for permissive hypotension in bleeding areas below the balloon, thus decreasing chances of hemorrhage. It is the smallest life-saving bleeding control device.
- In July 2021, Terumo Medical Corporation (TMC) announced the introduction of its AZUR Vascular Plug, the only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter.
- In September 2020, Boston Scientific Corporation received U.S. Food & Drug Administration (FDA) approval to launch WATCHMAN FLX, which is a Left Atrial Appendage Closure (LAAC) device. It is designed to seal off the Heart’s left atrial appendage to prevent blood clot formation.
Learn more about major clinical and commercial development in the Occlusion Devices Market @ Occlusion Devices Market – Clinical and Commercial Development Activities
Key Companies in the Occlusion Devices Market
Globally, some of the leading Occlusion Devices companies actively working in the market include Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others. Owing to the rising demand and favorable growth opportunities for revenue generation, several new players are anticipated to enter the market, thereby leading to high competitiveness in the domain.
Learn how new players’ entries will transform the Occlusion Devices market dynamics in the coming years @ Occlusion Devices Competitive Landscape
Scope of the Occlusion Devices Market Report:
- Study Period – 2020-2028
- Geography Covered – North America, Europe, Asia-Pacific, and Rest of the World
- Occlusion Devices Market Assessment –
-
-
- By Product Type – Embolization Devices, Occlusion Removal Devices [Coil Retrievers, Stent Retrievers, and Others
- By Support Devices
- By Application – Oncology, Cardiology, Vascular Diseases, Neurology, and Others
- By End-User – Hospitals, Surgical Centers, and Others
-
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s Views
Table of Content
| 1 | Report Introduction |
| 2 | Executive Summary |
| 3 | Regulatory and Patent Analysis in the Occlusion Devices Market |
| 4 | Occlusion Devices Market Key Factors Analysis |
| 5 | Occlusion Devices Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on the Occlusion Devices Market |
| 7 | Occlusion Devices Market Layout |
| 8 | Occlusion Devices Companies Share Analysis – Top 3–5 Companies |
| 9 | Occlusion Devices Companies and Major Product Profiles |
| 10 | Project Approach |
| 11 | KOL Views on Occlusion Devices Market |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Reach out to us to get a more detailed overview of the market @ Occlusion Devices Market Insights and Competitive Landscape
Other Trending Healthcare Reports by DelveInsight:
3d Cardiac Mapping System Market | Acute Pulmonary Embolism Market | Aortic Stenosis Market | Bile Duct Neoplasm Market | Carcinoid Tumor Market | Cluster Headache Market | Condyloma Market | Familial Primary Pulmonary Hypertension Market | Fibrocystic Breast Condition Market | Meningioma Market | Progressive Multifocal Leukoencephalopathy Market | Rhino Conjunctivitis Market | Ventilator Market |Intracranial Pressure Monitoring Devices Market | Hemodynamic Monitoring Systems Market | Automated External Defibrillators Market | Neurostimulation Devices Market | Neuroprosthetics Market | Eczema Market | Foot And Ankle Devices Market | Neuroblastoma Market | Pharmaceutical Consulting Companies | Allergic Conjunctivitis Market | Biotech Consulting | Cervical Intraepithelial Neoplasia Market | Osteoarthritis Market | Pruritus Market | Capnography Device Market | Image Guided Surgery Devices Market | Opioid Induced Constipation Market | Alzheimer Disease Market | Angioedema Market | Neurovascular Devices Market | Actinic Keratosis Market | Acute Coronary Syndrome Market | Blood Gas And Electrolyte Analyzers Market
Leverage the potential of consulting services to overcome the competition in the highly evolving and dynamic healthcare market with Healthcare Regulatory Analysis and Merger and Acquisitions in Healthcare Industry
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
Manager (Marketing & Branding)
info@delveinsight.com
+1(919)321-6187.